| |
|
|
 |
|
Composition |
Each ml contains:
Enrofloxacin: 100mg
Benzyl alcohol I.P. (as
preservative): 1.55 V/V |
| |
|
Indications |
| Infection of GI tract
such as diarrhoea,
enteritis, Colibacillosis,
etc. Infections of
respiratory tract such as
Pneumonia, acute and chronic
mastitis, Retained placenta,
Secondary infections
associated with viral
infections. |
| |
|
Dosage And Administration |
Large &Small animals:
2.5 - 5mg /kg b.wt, 2 -3
days by IM or IV route. |
| |
|
Salient Features |
| Achieves high
concentration at the site of
infection. Destroys the
proliferating organisms as
well as pathogens that are
in the dormant phase. Short
withdrawal period. No
plasmid mediated resistance. |
| |
|
Presentation |
| Vial of 15ml & 100 ml. |
|
|
| |
|
|
|
